Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024. In the quarter to June 2026, revenue grew 1.31%, EPS grew 2.17%, free cash flow grew 59.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

152.64 2.07 −1.34%
Market cap
$17.3B
P/E
72.7×
Fwd P/E
37.5×
Dividend yield
0.23%
F-score
6/9
Altman Z
2.49
Beneish M
−2.45
Dividend safety
80/100

Revvity Inc. (RVTY) Gross margin

Alert me on Gross margin

Revvity Inc.'s gross margin over the twelve months to 30 June 2026 was 55.0%, up 0.2 percentage points from fiscal 2025 (54.8%). Over the past ten years it has ranged from 45.8% (fiscal 2015) to 65.0% (fiscal 2020); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of 50.9% and in line with the Healthcare sector median of 53.5%.

Gross margin, annual

Embed this chart

Annual newest first

Period Gross margin Change (points)
FY2025 54.8% (1.04)
FY2024 55.8% (0.17)
FY2023 56.0% (4.10)
FY2022 60.1% (3.51)
FY2021 63.6% (1.38)
FY2020 65.0% 16.56
FY2019 48.4% 0.14
FY2018 48.3% 0.70
FY2017 47.6% (0.38)
FY2016 48.0% 2.14

Quarterly newest first

Period Gross margin Change (points)
Jun 2026 57.1% 2.62
Mar 2026 54.5% (0.11)
Dec 2025 54.6% 1.02
Sep 2025 53.6% (0.90)
42 more quarters

Against its own ten years

Low 45.8% High 65.0%
Ten-year median 54.8%
Current reading's percentile 52

Gross margin against peers

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on RVTY